IRIS
BELCARO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.764
AS - Asia 6.305
EU - Europa 5.792
SA - Sud America 1.218
AF - Africa 107
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 22.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.582
SG - Singapore 2.439
CN - Cina 1.659
BR - Brasile 969
UA - Ucraina 931
IE - Irlanda 903
IT - Italia 748
VN - Vietnam 695
TR - Turchia 689
RU - Federazione Russa 685
SE - Svezia 577
GB - Regno Unito 520
FR - Francia 424
DE - Germania 397
IN - India 254
FI - Finlandia 201
HK - Hong Kong 143
AR - Argentina 119
PL - Polonia 112
CA - Canada 69
ID - Indonesia 67
MX - Messico 66
BD - Bangladesh 60
ES - Italia 52
EC - Ecuador 43
JP - Giappone 43
BE - Belgio 40
KR - Corea 39
AU - Australia 38
NL - Olanda 38
ZA - Sudafrica 34
AT - Austria 31
IQ - Iraq 29
TH - Thailandia 29
PK - Pakistan 25
CH - Svizzera 24
CZ - Repubblica Ceca 24
IR - Iran 24
PY - Paraguay 22
CO - Colombia 19
VE - Venezuela 17
TN - Tunisia 16
EG - Egitto 15
TW - Taiwan 15
PT - Portogallo 14
EU - Europa 13
SA - Arabia Saudita 13
JO - Giordania 12
CL - Cile 11
MY - Malesia 11
PE - Perù 11
GR - Grecia 10
JM - Giamaica 10
LT - Lituania 10
MA - Marocco 10
UZ - Uzbekistan 10
NI - Nicaragua 9
PH - Filippine 9
CR - Costa Rica 8
RO - Romania 8
SK - Slovacchia (Repubblica Slovacca) 8
HR - Croazia 7
IL - Israele 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
KE - Kenya 6
DK - Danimarca 5
KZ - Kazakistan 5
NP - Nepal 5
SV - El Salvador 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
BG - Bulgaria 3
ET - Etiopia 3
LU - Lussemburgo 3
OM - Oman 3
UY - Uruguay 3
CG - Congo 2
GA - Gabon 2
GT - Guatemala 2
MK - Macedonia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SO - Somalia 2
TG - Togo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
Totale 22.226
Salva come PNG Salva come JPEG
Città #
Singapore 1.716
Jacksonville 1.182
Chandler 907
Dublin 896
San Jose 794
Ashburn 462
Princeton 438
Dallas 382
Izmir 363
Nanjing 349
Southend 346
Beijing 341
Council Bluffs 261
Ho Chi Minh City 253
Santa Clara 200
Wilmington 190
Cambridge 188
Altamura 183
Los Angeles 162
Hanoi 158
Ann Arbor 129
Tongling 129
Hong Kong 120
Nanchang 120
Dearborn 110
The Dalles 99
Moscow 89
New York 86
São Paulo 75
Boardman 72
Buffalo 69
Redondo Beach 66
Kraków 65
Shenyang 63
Hebei 56
Kunming 48
Tianjin 48
Atlanta 44
Woodbridge 44
Jiaxing 41
Munich 41
Da Nang 40
Orem 40
Milan 37
Warsaw 35
Rome 34
Tokyo 34
Catania 33
Changsha 31
London 31
Brussels 30
Norwalk 30
Rio de Janeiro 29
Boston 28
Chennai 28
Houston 28
Seattle 27
Haiphong 26
Washington 25
Brooklyn 24
Denver 24
Frankfurt am Main 24
Chieti 22
Curitiba 22
Hangzhou 22
Ankara 21
Falls Church 21
Sydney 21
Chicago 20
Mexico City 20
Vienna 20
Guangzhou 19
Memphis 19
Hefei 18
Manchester 18
Mumbai 18
Amsterdam 17
Istanbul 17
Johannesburg 17
Lanzhou 17
Belo Horizonte 16
Brno 16
Grevenbroich 16
Biên Hòa 15
Montreal 15
San Mateo 15
Toronto 15
Guayaquil 14
Helsinki 14
Hải Dương 14
Jinan 14
Shanghai 14
Foggia 13
Pune 13
San Francisco 13
Thái Bình 13
Augusta 12
Bangkok 12
Changchun 12
Ningbo 12
Totale 12.650
Salva come PNG Salva come JPEG
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 594
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 246
Venoruton vs Daflon: evaluation of effects on qualità of life chronic venous insuffciency 205
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 201
Improvement of common cold with Pycnogenol®: a Winter registry study 182
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 170
Prevention of edema in long flights with Pycnogenol 169
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 166
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 160
Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids. 159
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 156
Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress 154
Incidence of perioperative stroke during peripheral revascularization or aortocoronary bypass in patients with carotid bruit and stenosis 153
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 151
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 148
Topical heparin: New observations 146
Postoperative pulmonary infections: role of antibiotic treatment 144
Mononucleosis-related fatigue: supplementary management with Robuvit®. 144
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 142
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 141
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study 141
Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins 140
Jet-lag: prevention with Pycnogenol. Preliminary report: evaluation in healthy individuals and in hypertensive patients 140
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 140
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 139
[Breast cancer. Epidemiology and other factors related to incidence in various populations]. 138
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 137
Treatment of Osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of Signs, Symptoms,Physical Performance and Vascular Aspects 135
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 134
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 134
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 133
Treatment of ankle sprain in patients with vascular diseases of the lower limbs 133
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 133
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 132
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. 131
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 131
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 130
[Comparison of netilmicin with other aminoglycosides in severe surgical infections]. 130
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 130
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report. 129
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 129
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 128
Circulating endothelail cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton 127
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. 127
Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study. 127
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 127
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 127
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 125
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 124
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry 123
Superficial vein thrombosis (SVT), diffusion of thrombotic diseases, and increased global thrombogenicity: SVT as an important spy disease indicating environmental contamination by estrogens - Introduction 123
A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers. 123
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 122
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 122
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. 121
Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study 121
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 121
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 121
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 121
Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol 120
Microcirculatory effects of Viatromb® spray gel heparin in chronic venous insufficiency: Evaluation of TcPO2 and PCO2 - A product evaluation study 120
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 120
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 119
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography. 118
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. 118
Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation. 118
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 118
The value of segmental pressure measurement in the assessment of peripheral vascular disease. 117
Robuvit®: improvement of fatigue in medical convalescence. 116
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 116
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study 115
Improvement of common cold with Pycnogenol®: a Winter registry study. 115
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 115
Cramps and Muscular Pain: Prevention with Pycnogenol((R)) in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy 113
Pycnogenol may alleviate adverse effects in oncologic treatment 113
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 113
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 112
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. 111
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 110
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 110
Local heparin, superficial vein thrombosis 110
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 109
Computerized ultrasonic angiography. Current applications and comparison with other noninvasive and invasive methods 109
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 108
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 108
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 107
A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment 107
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 107
A plaster combining diclofenac and heparin: microcirculatory evaluation in 2 models of high-perfusion microangiopathy 106
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 106
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). 106
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome 106
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 106
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 105
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 105
Lady Prelox® improves sexual function in generally healthy women of reproductive age. 105
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 105
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 103
Effects of shock waves on microcirculation, perfusion, and pain management in critical limb ischemia. 102
THE VENOUS CLINIC 102
Totale 13.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022870 16 18 15 166 77 25 19 65 68 17 101 283
2022/20232.720 272 406 156 284 234 570 180 176 276 26 88 52
2023/20241.146 88 50 65 26 48 287 334 38 24 50 33 103
2024/20253.392 264 688 530 55 78 93 64 149 394 147 281 649
2025/20267.382 486 302 956 1.378 544 367 886 504 724 543 447 245
2026/2027386 386 0 0 0 0 0 0 0 0 0 0 0
Totale 22.730